Clinical Trials Browser

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Epstein-Barr Virus Infections

NCT02630537 2015-12-15

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Completed

133 enrolled

Epstein-Barr Virus Infections

NCT00129584 2009-08-18

Endobronchial Valve for Emphysema Palliation Trial (VENT)

Phase 3 Completed

270 enrolled

Emphysema, Epstein-Barr Virus Infections, Pulmonary Disease, Chronic Obstructive

NCT00430534 2007-02-02

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

Phase 2 Completed

200 enrolled

Infections, Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT00002026 2005-06-24

Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)

Phase NA Completed

Head & Neck

AIDS-Related Complex, Leukoplakia, Oral, HIV Infections, AIDS-Related Opportunistic Infections, Leukoplakia, Hairy, Epstein-Barr Virus Infections

Clinical Trials

Prevent

VANCE

CHARMS

Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients

ARMS

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Endobronchial Valve for Emphysema Palliation Trial (VENT)

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)